US Patent Issued to SHENZHEN YANDAI INVESTMENT on Aug. 12 for "Polysaccharide compound with a defined molecular structure that can eliminate the toxic side effects of chemotherapy drugs" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,577, issued on Aug. 12, was assigned to SHENZHEN YANDAI INVESTMENT Co. LTD (Guangdong, China).

"Polysaccharide compound with a defined molecular structure that can eliminate the toxic side effects of chemotherapy drugs" was invented by Xuemin Chen (Guangdong, China), Chunming He (Guangdong, China), Guan Mo (Guangdong, China), Jin Chen (Guangdong, China), Yanjun Li (Guangdong, China), Yao Chen (Guangdong, China), Fengji Chen (Guangdong, China), Mei Liang (Guangdong, China), Zhe Fang (Guangdong, China) and Yuanye Su (Guangdong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention pertains to the field of plant extraction and separation ...